Highlights
NASDAQ: BIIB       Biogen Inc Cmn
Last Price Today's Change   Day's Range   Trading Volume
280.23   -6.66 (2.32%)  279.88 - 286.89  1,085,696

Overview

Avg Volume (4 weeks):1,543,226
4 Weeks Range:267.10 - 291.90
52 Weeks Range:223.02 - 333.65
Average Price Target: 446.00
Price Target Upside/Downside: +165.77

Headlines



No recent Headlines for this stock.


Business Background

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; BIIB061; BIIB054; BIIB067, and BIIB068.

  Be the first to like this.
 


 

4720  2281  573  751 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CSQ 11.43+0.02 
 BNCL 16.95+0.35 
 GALT 3.129-0.141 
 BBRY 9.190.00 
 NUGT 7.765-0.405 
 X 23.297-7.813 
 TWTR 15.981+1.321 
 BAC 24.13+0.15 
 SPY 239.34+0.79 
 EEM 40.08-0.12 
Partners & Brokers